日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer.

口服血红素加氧酶抑制剂靶向癌症临床前模型中的免疫抑制性血管周围巨噬细胞

Bahri Meriem, Al-Adhami Taha, Demirel Emre, Sarkar Jit, Feehan Karen T, Anstee Joanne E, Cheung Tik Shing, Sosnowska Dominika, Woodman Chloé A, Macmorland William, Yang Dorothy D, Rosekilly James, Gitsaki-Taylor Renee, Gillett Cheryl E, Scudamore Cheryl L, Spicer James, Rahman Khondaker Miraz, Arnold James N

Tumor microenvironments with an active type I IFN response are sensitive to inhibitors of heme degradation

具有活跃的I型干扰素反应的肿瘤微环境对血红素降解抑制剂敏感

Dominika Sosnowska ,Tik Shing Cheung ,Jit Sarkar ,James W Opzoomer ,Karen T Feehan ,Joanne E Anstee ,Chloé A Woodman ,Mohamed Reda Keddar ,Kalum Clayton ,Samira Ali ,William Macmorland ,Dorothy D Yang ,James Rosekilly ,Cheryl E Gillett ,Francesca D Ciccarelli ,Richard Buus ,James Spicer ,Anita Grigoriadis ,James N Arnold

Cohort profile: King's Health Partners bladder cancer biobank

队列概况:国王健康伙伴膀胱癌生物样本库

Kotecha, Pinky; Moss, Charlotte L; Enting, Deborah; Gillett, Cheryl; Joseph, Magdalene; Josephs, Debra; Rudman, Sarah; Hughes, Simon; Cahill, Fidelma; Wylie, Harriet; Haire, Anna; Rosekilly, James; Khan, Muhammad Shamin; Nair, Rajesh; Thurairaja, Ramesh; Malde, Sachin; Van Hemelrijck, Mieke

Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

使用泛 ErbB 重靶向 CAR-T 细胞对恶性间皮瘤进行腔内“T4 免疫治疗”

Astero Klampatsa, Daniela Y Achkova, David M Davies, Ana C Parente-Pereira, Natalie Woodman, James Rosekilly, Georgina Osborne, Thivyan Thayaparan, Andrea Bille, Michael Sheaf, James F Spicer, Juliet King, John Maher